Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin
Completed
Eli Lilly and Company
Phase 4
2001-08-01
The purposes of this study are to determine: 1. If patients taking insulin lispro LM with
metformin will have better overall control of their blood sugar than patients taking a long
acting insulin comparator with metformin. 2. If there is a difference in the way the two
treatments affect blood sugar control before and after meals and at night. 3. If there is a
difference in the insulin dose required with the two treatments. 4. If there is a difference
in the numbers of times patients experience low blood sugar with the two treatments. 5. If
there is a difference in the effect on patients's body weight.
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
Completed
Sanofi
Phase 3
2002-11-01
The purpose of the study is to compare the effect in blood sugar control between Lantus and
twice daily intermediate acting insulins (NPH or Lente) when used as the basal insulin in a
multiple daily injection setting with fast acting insulin (Lispro)
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Completed
Novo Nordisk A/S
Phase 3
2002-06-01
This trial is conducted in the United States of America (USA). The aim of this trial is to to
determine whether insulin aspart can be used effectively and safely in paediatric patients.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
